Association for Molecular Pathology


October 2011, Volume 17, Number 3


AMP Canadian Interest Group
Annual Report of Activities 2011

Formalizing an Association with AMP as an Interest group

For many years, a number of Canadian members of AMP have taken the opportunity to meet during the annual meeting to discuss common issues such as quality assurance, emerging technologies, sample exchange and patents affecting molecular diagnostics. The format of the meetings is a brief pre-meeting opportunity to mingle and meet one another followed by 2 or 3 short lectures with opportunity for discussion. Dinner is served after the lectures, with an opportunity for further discussion of topics of interest during dinner. The format of these meetings has allowed us to get to know each other on both a professional and a personal level. As these interactions are of value to Canadian members and because we would like to encourage further attendance through the AMP annual meeting we believe that formalizing our interactions as an AMP interest group would benefit both the Canadian members and AMP as a whole.

A list of members has been generated by asking all Canadian AMP members if they were interested in becoming a founding member of the AMP Canadian interest group.

Planning for the Canadian Dinner at the Annual Meeting

Dinner will be held at 7pm on Thursday, November 17 at the Gaylord Hotel after the Welcome Reception. This year, 2 lectures will be given, focusing on QA/QC issues specific to new technologies. For 2012, we would like to focus on developing networks to aid in standardizing testing across the provinces, through the sharing of protocols and sample exchanges. Further goals and objectives will be discussed at the meeting.

This event has been sponsored by a number of Pharmaceutical companies, including Roche Canada, Novartis Canada and Bristol-Myers Squibb Canada.

Respectfully Submitted,
Co-Chairs, AMP Canadian Interest Group

Dr. Suzanne Kamel-Reid, PhD, DABMG, FACMG
Head, Laboratory Genetics and
Director, Molecular Diagnostics
The University Health Network
Senior Scientist
The Ontario Cancer Institute
The University of Toronto, ON


Dr. Wenda Greer, PhD, FCCMG
Director, DNA Diagnostic Laboratory
Department of Pathology and Laboratory Medicine
Capital District Health Authority
Professor, Department of Pathology
Dalhousie University, Halifax, NS